Haissaguerre M - Search Results

1

The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice.

Bermudez-Silva FJ, Romero-Zerbo SY, Haissaguerre M, Ruz-Maldonado I, Lhamyani S, El Bekay R, Tabarin A, Marsicano G, Cota D. Bermudez-Silva FJ, et al. Among authors: haissaguerre m. Dis Model Mech. 2016 Jan;9(1):51-61. doi: 10.1242/dmm.020750. Epub 2015 Nov 12. Dis Model Mech. 2016. PMID: 26563389 Free PMC article.

2

Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics.

Haissaguerre M, Courel M, Caron P, Denost S, Dubessy C, Gosse P, Appavoupoulle V, Belleannée G, Jullié ML, Montero-Hadjadje M, Yon L, Corcuff JB, Fagour C, Mazerolles C, Wagner T, Nunes ML, Anouar Y, Tabarin A. Haissaguerre M, et al. J Clin Endocrinol Metab. 2013 Nov;98(11):4346-54. doi: 10.1210/jc.2013-1844. Epub 2013 Sep 3. J Clin Endocrinol Metab. 2013. PMID: 24001749

3

Influence of mTOR in energy and metabolic homeostasis.

Haissaguerre M, Saucisse N, Cota D. Haissaguerre M, et al. Mol Cell Endocrinol. 2014 Nov;397(1-2):67-77. doi: 10.1016/j.mce.2014.07.015. Epub 2014 Aug 7. Mol Cell Endocrinol. 2014. PMID: 25109278 Review.

4

[New insights in adrenal Cushing syndrome].

Haissaguerre M, Tabarin A. Haissaguerre M, et al. Ann Endocrinol (Paris). 2014 Oct;75 Suppl 1:S37-45. doi: 10.1016/S0003-4266(14)70025-3. Ann Endocrinol (Paris). 2014. PMID: 25617921 French.

5

[Role of the mTOR pathway in the central regulation of energy balance].

Haissaguerre M, Cota D. Haissaguerre M, et al. Biol Aujourdhui. 2015;209(4):295-307. doi: 10.1051/jbio/2016009. Epub 2016 Mar 28. Biol Aujourdhui. 2015. PMID: 27021048 Review. French.

6

Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.

Guerin C, Pattou F, Brunaud L, Lifante JC, Mirallié E, Haissaguerre M, Huglo D, Olivier P, Houzard C, Ansquer C, Hindié E, Loundou A, Archange C, Tabarin A, Sebag F, Baumstarck K, Taïeb D. Guerin C, et al. Among authors: haissaguerre m. J Clin Endocrinol Metab. 2017 Jul 1;102(7):2465-2472. doi: 10.1210/jc.2017-00254. J Clin Endocrinol Metab. 2017. PMID: 28431167

7

Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists.

Hindié E, Morgat C, Zanotti-Fregonara P, Haissaguerre M, Bordenave L, Tabarin A. Hindié E, et al. Among authors: haissaguerre m. J Nucl Med. 2018 Mar;59(3):546-547. doi: 10.2967/jnumed.117.202630. Epub 2017 Oct 6. J Nucl Med. 2018. PMID: 28986513 Free article. No abstract available.

8

mTORC1-dependent increase in oxidative metabolism in POMC neurons regulates food intake and action of leptin.

Haissaguerre M, Ferrière A, Simon V, Saucisse N, Dupuy N, André C, Clark S, Guzman-Quevedo O, Tabarin A, Cota D. Haissaguerre M, et al. Mol Metab. 2018 Jun;12:98-106. doi: 10.1016/j.molmet.2018.04.002. Epub 2018 Apr 13. Mol Metab. 2018. PMID: 29699927 Free PMC article.

9

NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin.

Haissaguerre M, Ferriere A, Clark S, Guzman-Quevedo O, Tabarin A, Cota D. Haissaguerre M, et al. Front Pharmacol. 2018 May 15;9:527. doi: 10.3389/fphar.2018.00527. eCollection 2018. Front Pharmacol. 2018. PMID: 29867515 Free PMC article.

10

Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?

Ollivier M, Haissaguerre M, Ferriere A, Tabarin A. Ollivier M, et al. Among authors: haissaguerre m. Eur J Endocrinol. 2018 Oct 12;179(5):L1-L2. doi: 10.1530/EJE-18-0694. Eur J Endocrinol. 2018. PMID: 30320504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

972 results

Search Page